212 related articles for article (PubMed ID: 31799703)
61. Combined immunodeficiencies due to defects in signal transduction: defects of the gammac-JAK3 signaling pathway as a model.
Notarangelo LD; Giliani S; Mella P; Schumacher RF; Mazza C; Savoldi G; Rodriguez-Pérez C; Badolato R; Mazzolari E; Porta F; Candotti F; Ugazio AG
Immunobiology; 2000 Aug; 202(2):106-19. PubMed ID: 10993286
[TBL] [Abstract][Full Text] [Related]
62. The γ
Leonard WJ; Lin JX; O'Shea JJ
Immunity; 2019 Apr; 50(4):832-850. PubMed ID: 30995502
[TBL] [Abstract][Full Text] [Related]
63. [A compound heterozygosity mutation in the interleukin-7 receptor-alpha gene resulted in severe combined immunodeficiency in a Chinese patient].
Zhang ZY; Zhao XD; Wang M; Yu J; An YF; Yang XQ
Zhonghua Er Ke Za Zhi; 2009 Sep; 47(9):691-5. PubMed ID: 20021794
[TBL] [Abstract][Full Text] [Related]
64. Genome profiling revealed the activation of IL2RG/JAK3/STAT5 in peripheral T‑cell lymphoma expressing the ITK‑SYK fusion gene.
Zhang LL; Pan HX; Wang YX; Guo T; Liu L
Int J Oncol; 2019 Nov; 55(5):1077-1089. PubMed ID: 31545408
[TBL] [Abstract][Full Text] [Related]
65. Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis.
Bauer JH; Liu KD; You Y; Lai SY; Goldsmith MA
J Biol Chem; 1998 Apr; 273(15):9255-60. PubMed ID: 9535918
[TBL] [Abstract][Full Text] [Related]
66. Glomerular common gamma chain confers B- and T-cell-independent protection against glomerulonephritis.
Luque Y; Cathelin D; Vandermeersch S; Xu X; Sohier J; Placier S; Xu-Dubois YC; Louis K; Hertig A; Bories JC; Vasseur F; Campagne F; Di Santo JP; Vosshenrich C; Rondeau E; Mesnard L
Kidney Int; 2017 May; 91(5):1146-1158. PubMed ID: 28111009
[TBL] [Abstract][Full Text] [Related]
67. X-linked SCID and other defects of cytokine pathways.
Uribe L; Weinberg KI
Semin Hematol; 1998 Oct; 35(4):299-309. PubMed ID: 9801259
[TBL] [Abstract][Full Text] [Related]
68. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
[TBL] [Abstract][Full Text] [Related]
69. Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia.
Kiel MJ; Velusamy T; Rolland D; Sahasrabuddhe AA; Chung F; Bailey NG; Schrader A; Li B; Li JZ; Ozel AB; Betz BL; Miranda RN; Medeiros LJ; Zhao L; Herling M; Lim MS; Elenitoba-Johnson KS
Blood; 2014 Aug; 124(9):1460-72. PubMed ID: 24825865
[TBL] [Abstract][Full Text] [Related]
70. Multiple reversions of an IL2RG mutation restore T cell function in an X-linked severe combined immunodeficiency patient.
Kawai T; Saito M; Nishikomori R; Yasumi T; Izawa K; Murakami T; Okamoto S; Mori Y; Nakagawa N; Imai K; Nonoyama S; Wada T; Yachie A; Ohmori K; Nakahata T; Heike T
J Clin Immunol; 2012 Aug; 32(4):690-7. PubMed ID: 22460439
[TBL] [Abstract][Full Text] [Related]
71. Mutation analyses and prenatal diagnosis in families of X-linked severe combined immunodeficiency caused by IL2Rγ gene novel mutation.
Bai QL; Liu N; Kong XD; Xu XJ; Zhao ZH
Genet Mol Res; 2015 Jun; 14(2):6164-72. PubMed ID: 26125817
[TBL] [Abstract][Full Text] [Related]
72. Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report.
Abd Hamid IJ; Slatter MA; McKendrick F; Pearce MS; Gennery AR
Blood; 2017 Apr; 129(15):2198-2201. PubMed ID: 28209722
[TBL] [Abstract][Full Text] [Related]
73. Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.
Mamcarz E; Zhou S; Lockey T; Abdelsamed H; Cross SJ; Kang G; Ma Z; Condori J; Dowdy J; Triplett B; Li C; Maron G; Aldave Becerra JC; Church JA; Dokmeci E; Love JT; da Matta Ain AC; van der Watt H; Tang X; Janssen W; Ryu BY; De Ravin SS; Weiss MJ; Youngblood B; Long-Boyle JR; Gottschalk S; Meagher MM; Malech HL; Puck JM; Cowan MJ; Sorrentino BP
N Engl J Med; 2019 Apr; 380(16):1525-1534. PubMed ID: 30995372
[TBL] [Abstract][Full Text] [Related]
74. Mutation Analysis of Three Infantile Cases of X-linked Severe Combined Immunodeficiency.
Yu C; Wang Y; Min L
Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013372
[TBL] [Abstract][Full Text] [Related]
75. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
Zhang Q; Lee B; Korecka M; Li G; Weyland C; Eck S; Gessain A; Arima N; Lessin SR; Shaw LM; Luger S; Kamoun M; Wasik MA
Leuk Res; 1999 Apr; 23(4):373-84. PubMed ID: 10229324
[TBL] [Abstract][Full Text] [Related]
76. Analysis of Mutations in the IL2RG Gene in 2 Asian Infants With X-linked Severe Combined Immunodeficiency.
Hara Y; Kobayashi N; Maruyama Y; Motobayashi M; Shigemura T; Ohara O; Agematsu K; Koike K
J Investig Allergol Clin Immunol; 2015; 25(4):313-5. PubMed ID: 26310054
[No Abstract] [Full Text] [Related]
77. Novel mutation of IL2RG gene in a Korean boy with X-linked severe combined immunodeficiency.
Lee YW; Yang EA; Kang HJ; Yang X; Mitsuiki N; Ohara O; Miyawaki T; Kanegane H; Lee JH
J Investig Allergol Clin Immunol; 2013; 23(1):65-7. PubMed ID: 23653982
[No Abstract] [Full Text] [Related]
78. Jak1 has a dominant role over Jak3 in signal transduction through γc-containing cytokine receptors.
Haan C; Rolvering C; Raulf F; Kapp M; Drückes P; Thoma G; Behrmann I; Zerwes HG
Chem Biol; 2011 Mar; 18(3):314-23. PubMed ID: 21439476
[TBL] [Abstract][Full Text] [Related]
79. Eleven novel JAK3 mutations in patients with severe combined immunodeficiency-including the first patients with mutations in the kinase domain.
Mella P; Schumacher RF; Cranston T; de Saint Basile G; Savoldi G; Notarangelo LD
Hum Mutat; 2001 Oct; 18(4):355-6. PubMed ID: 11668621
[TBL] [Abstract][Full Text] [Related]
80. Nuclease-free Adeno-Associated Virus-Mediated Il2rg Gene Editing in X-SCID Mice.
Hiramoto T; Li LB; Funk SE; Hirata RK; Russell DW
Mol Ther; 2018 May; 26(5):1255-1265. PubMed ID: 29606506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
